Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When - Biology of Cardiovascular Diseases Accéder directement au contenu
Article Dans Une Revue Journal of the American Medical Directors Association Année : 2021

Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When

Résumé

To describe the rationale for subcutaneous (SC) administration of antibiotics from available published data and to make propositions to help clinicians in daily practice. Narrative review. Hospitalized patients, persons in long-term care facilities and ambulatory care. We searched the MEDLINE/PubMed electronic database for evidence supporting SC administration of antibiotics up to September 2019; the results of this primary search were supplemented by searching the references of the identified articles, as well as by searching in Google Scholar. Regarding tolerability, efficacy, and pharmacokinetic/pharmacodynamic profiles, most studies suggest that the SC route could be an alternative to the intravenous route, particularly for time-dependent antibiotics and among certain patient populations, such as patients with poor venous access, swallowing disorders, or behavioral disturbance. However, clinical evidence of the benefits and risks of SC antibiotic administration is still scarce and of low level. SC administration of antibiotics may be useful in various settings such as in hospitalized patients and among those in long-term care facilities or being cared for at home. However, further clinical studies are needed to assess the pharmacokinetic/pharmacodynamic properties, as well as the risks and benefits of SC administration of antibiotics. In this review, we highlight the potential benefits of SC administration of antibiotics and address practical recommendations for its use. This information will enable improvement of treatment strategies and present the SC route as a potential option in specific situations.
Fichier principal
Vignette du fichier
S1525861020303637.pdf (299.66 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03194481 , version 1 (02-01-2023)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Virgilio Hernández-Ruiz, Emmanuel Forestier, Gaëtan Gavazzi, Tristan Ferry, Nicolas Grégoire, et al.. Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When. Journal of the American Medical Directors Association, 2021, 22 (1), pp.50-55.e6. ⟨10.1016/j.jamda.2020.04.035⟩. ⟨hal-03194481⟩
59 Consultations
243 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More